Note: Ingredients listed on restricted chemical lists
EC/CAS
298-81-7
Name of the chemical
Furocoumarines (e. g. trioxysalen (INN), 8-methoxypsoralen, 5-methoxypsoralen) except for normal content in natural essences used. In sun protection and in bronzing products, furocoumarines shall be below 1 mg/kg
Concentration
N/A
General Information
Product name
Methoxsalen Capsules USP 10mg
CAS No.
298-81-7
Icons in SDS
Company Information
company name
Strides Arcolab Ltd
Section 2
SECTION 2: Hazards identification
Fire and Explosion Slightly flammable to flammable in presence of heat. Slightly explosive in presence of open flames and sparks Health Caution - METHOXSALEN IS A POTENT DRUG. Methoxsalen with UV radiation should be used only by physicians who have special competence in the diagnosis and treatment of psoriasis and vitiligo and who have special training and experience in photochemotherapy. Psoralen and ultraviolet radiation therapy should be under constant supervision of such a physician. For the treatment of patients with psoriasis, photochemotherapy should be restricted to patients with severe, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis is certain. Because of the possibilities of ocular damage, aging of the skin, and skin cancer (including melanoma), the patient should be fully informed by the physician of the risks inherent in this therapy. When methoxsalen is used in combination with photopheresis, refer to the UVAR* System Operator’s Manual for specific warnings, cautions, indications, and instructions related to photopheresis. Over exposure effects Can cause severe burns in conjunction with UVA light, either artificial or sunlight. Irritation to mucous membranes, headache and drowsiness if inhaled beyond normal. Protection of first-aiders Use personal protective equipment. Ensure that medical personnel are aware of the material(s) involved, and take precautions to protect themselves.